{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:22:36Z","timestamp":1791278556031,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.earlhumdev.2011.01.027","type":"journal-article","created":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T04:33:14Z","timestamp":1297225994000},"page":"S39-S42","source":"Crossref","is-referenced-by-count":26,"special_numbering":"S","title":["Erythropoietin and retinopathy of prematurity"],"prefix":"10.1016","volume":"87","author":[{"given":"C.","family":"Romagnoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Tesfagabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Giannantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Papacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mpd.2002.124309","article-title":"Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000g","volume":"141","author":"Maier","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","article-title":"Erythropoietin: physiology and pharmacology update","volume":"228","author":"Fisher","year":"2003","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0015","first-page":"CD004865","article-title":"Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"3","author":"Aher","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0020","first-page":"CD004863","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"3","author":"Ohlsson","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0025","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1097\/MPH.0b013e3181cf444c","article-title":"Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization","volume":"32","author":"Zuppa","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000047097","article-title":"The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential","volume":"79","author":"Dame","year":"2001","journal-title":"Biol Neonate"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4419-8997-0_22","article-title":"Nonerythroid. functions of erythropoietin","volume":"543","author":"Gassmann","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00277-004-0911-6","article-title":"Beneficial and ominous aspects of the pleiotropic action of erythropoietin","volume":"83","author":"Jelkmann","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cardiores.2006.07.024","article-title":"A cordial affair: erythropoietin and cardioprotection","volume":"72","author":"Fandrey","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0050","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","article-title":"Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization","volume":"102","author":"Heeschen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0055","first-page":"1","article-title":"Erythropoietin and VEGF exhibit equal angiogenic potential","volume":"228","author":"Jaquet","year":"2002","journal-title":"Microvasc Res"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-3782(98)00030-9","article-title":"Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus","volume":"52","author":"Juul","year":"1998","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0065","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.90.9.4304","article-title":"General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1067\/mpa.2001.113843","article-title":"Decreased incidence of retinopathy of prematurity, 1995\u20131997","volume":"5","author":"Blair","year":"2001","journal-title":"J AAPOS"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1091-8531(99)70094-7","article-title":"The decreasing incidence and severity of retinopathy of prematurity","volume":"3","author":"Bullard","year":"1999","journal-title":"J AAPOS"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3928\/01913913-20080501-12","article-title":"An epidemiologic analysis of retinopathy of prematurity over 10years","volume":"45","author":"Giannantonio","year":"2008","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0090","doi-asserted-by":"crossref","first-page":"F251","DOI":"10.1136\/adc.2006.096479","article-title":"The NICUS Group. Severe retinopathy of prematurity in infants ,30weeks' gestation in New South Wales and the Australian Capital Territory from 1992 to 2002","volume":"92","author":"Todd","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0095","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0100","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0105","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","article-title":"Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity","volume":"98","author":"Hellstrom","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0110","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstrom","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1084-2756(03)00119-2","article-title":"Pathogenesis of retinopathy of prematurity","volume":"8","author":"Smith","year":"2003","journal-title":"Semin Neonatol"},{"issue":"10 suppl","key":"10.1016\/j.earlhumdev.2011.01.027_bb0120","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.earlhumdev.2009.08.026","article-title":"Risk factors and growth factors in ROP","volume":"85","author":"Romagnoli","year":"2009","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0125","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/PL00008390","article-title":"Do recombinant human erythropoietin (rhEPO) and Iron supplementation increase the risk of retinopathy of prematurity?","volume":"159","author":"Romagnoli","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1651-2227.1990.tb11348.x","article-title":"Oxygen toxicity in the neonatal period","volume":"79","author":"Saugstad","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0135","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1542\/peds.78.6.1171","article-title":"Retinopathy of prematurity and iron: a modification of the oxygen hypothesis","volume":"78","author":"Sullivan","year":"1986","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0140","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1056\/NEJM200511173532015","article-title":"Erythropoietin as a retinal angiogenic factor","volume":"353","author":"Manzoni","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0145","first-page":"CD004868","article-title":"Late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"3","author":"Aher","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaapos.2005.09.005","article-title":"Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity","volume":"10","author":"Brown","year":"2006","journal-title":"J AAPOS"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2007-2591","article-title":"An approach to using recombinant erythropoietin for neuroprotection in very preterm infants","volume":"122","author":"Fauchere","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1203\/PDR.0b013e3181bc33e6","article-title":"High-dose erythropoietin does not exacerbate retinopathy of prematurity in rats","volume":"66","author":"Slusarski","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0170","first-page":"526","article-title":"Erythrpoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0175","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ki.1995.113","article-title":"Recombinant human erythropoietin stimulates angiogenesis in vitro","volume":"47","author":"Carlini","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0180","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","article-title":"Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo","volume":"3","author":"Ribatti","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0185","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","article-title":"Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy","volume":"353","author":"Watanabe","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-0-387-34817-9_11","article-title":"Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration","volume":"588","author":"Grimm","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0195","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMcibr022629","article-title":"Erythropoietin\u2014an endogenous retinal survival factor","volume":"347","author":"Becerra","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0200","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1203\/PDR.0b013e318165b8d1","article-title":"Elevated erythropoietin mRNA and protein concentrations in the developing human eyes","volume":"63","author":"Patel","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0205","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","article-title":"Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0210","first-page":"221","article-title":"A double-edged sword: erythropoietin eyed in retinopathy of prematurity","volume":"116","author":"Chen","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.earlhumdev.2011.01.027_bb0215","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.ophtha.2009.04.024","article-title":"Stimulating angiogenesis to prevent ischemic retinopathy","volume":"116","author":"Sears","year":"2009","journal-title":"Ophthalmology"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378211000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378211000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:41:25Z","timestamp":1685925685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378211000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":43,"alternative-id":["S0378378211000648"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2011.01.027","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}